|
Apr 22
|
AstraZeneca rejoins leading U.S. drug lobby group after two-year absence
|
|
Apr 22
|
Daiichi and AstraZeneca’s Enhertu shows PFS benefits in breast cancer trial
|
|
Apr 21
|
Cellectis SA (CLLS) Q4 2024 Earnings Call Highlights: Strategic Collaborations and Financial ...
|
|
Apr 21
|
AstraZeneca (LSE:AZN) and Daiichi Sankyo's ENHERTU Shows Promising Results in HER2 Breast Cancer Trial
|
|
Apr 21
|
Should You Buy, Sell or Hold AstraZeneca Stock Before Q1 Earnings?
|
|
Apr 21
|
AstraZeneca- Daiichi Sankyo's Multi-Billion Dollar Cancer Drug Shows Superior Efficacy Across Broad HER2 Positive Metastatic Breast Cancer Patients
|
|
Apr 21
|
ENHERTU® (fam-trastuzumab deruxtecan-nxki) plus pertuzumab demonstrated highly statistically significant and clinically meaningful improvement in progression-free survival vs. THP as 1st-line therapy for patients with HER2+ metastatic breast cancer
|
|
Feb 15
|
AstraZeneca: IMFINZI improved event-free survival, OS across MIBC
|
|
Feb 15
|
2 Healthcare Stocks That Tumbled in 2024...but Could See an Impressive Comeback in 2025
|
|
Feb 14
|
IMFINZI® (durvalumab) perioperative regimen improved event-free survival and overall survival across muscle-invasive bladder cancer patients regardless of complete pathology response status in post-hoc exploratory analysis of NIAGARA Phase III trial
|
|
Feb 14
|
Is AstraZeneca PLC (AZN) the Best Foreign Dividend Stock to Buy According to Analysts?
|
|
Feb 12
|
3 UK Stocks That May Be Undervalued Based On Current Estimates
|
|
Feb 12
|
AstraZeneca PLC (AZN): Among the Best International Dividend Stocks to Buy Now
|
|
Feb 11
|
Is AstraZeneca PLC (AZN) the Safest Dividend Stock in the UK?
|
|
Oct 12
|
AstraZeneca PLC (AZN): A Top Holding in George Soros’s Portfolio
|
|
Oct 9
|
Astrazeneca (AZN) Loses -5.29% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
|
|
Oct 8
|
AstraZeneca Inks Agreement to Boost Cardiovascular Pipeline
|
|
Oct 8
|
Health Care Roundup: Market Talk
|
|
Oct 8
|
Want to Invest in the Weight Loss Boom? Consider Buying These 2 Stocks
|
|
Oct 8
|
AstraZeneca’s Phase III trial of treatment for asthma meets its primary endpoint
|